Besides, our results also showed that decitabine-induced ROS raise led to ferroptosis in MDS cells by decreasing GSH level and GPX4 activity, which further clarified the mechanism of ferroptosis induced by decitabine. This evidence concerns the gene GPX4 and myelodysplastic syndrome.